US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bristol-Myers Squibb

47.73

-0.9300-1.92%

Volume:565.66K

Turnover:10.89M

Market Cap:97.11B

PE:-10.81

High:47.95

Open:47.94

Low:47.60

Close:48.53

Loading ...

Overview Company News Filings

8 key drug patents expiring soon — and what it means for the market

Is Bristol-Myers Squibb (BMY) Among the Cheap Stocks to Buy According to Billionaires?

Bristol Myers Squibb Co. Stock Outperforms Competitors On Strong Trading Day

Bristol Myers Squibb call volume above normal and directionally bullish

Is VanEck Morningstar Wide Moat ETF (MOAT) a Strong ETF Right Now?

2 High-Yield Dividend Stocks That Are Bargain Buys Right Now

Bristol Myers Squibb (BMY) Ascends But Remains Behind Market: Some Facts to Note

Actinium Pharmaceuticals Launches Clinical Program to Evaluate Actimab-A as Combination Cancer Therapy

MT Newswires Live

Bristol-Myers Squibb Company (BMY): A Bull Case Theory

Perspective Therapeutics Starts Dosing New Cohort for Melanoma Tumor Treatment Therapy

MT Newswires Live

BRIEF-CMS Announces Manufacturer Participation in Second Cycle of Medicare Drug Price Negotiation

Bristol Myers Squibb Co. Stock Underperforms Friday When Compared To Competitors

BUZZ - S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT

Bristol-Myers Squibb (NYSE:BMY) Gets EC Nod For Breyanzi In NHL Treatment

Simply Wall St.

Bristol-Myers Squibb Says EU Approves Breyanzi for Relapsed, Refractory Follicular Lymphoma

MT Newswires Live

Bristol Myers Gets Expanded European Approval for Breyanzi

Bristol Myers announces EC approval of Breyanzi

BRIEF-Bristol Myers Squibb Receives Approval From The European Commission To Expand Use Of Car T Cell Therapy Breyanzi For Relapsed Or Refractory Follicular Lymphoma

Bristol Myers Squibb Receives Approval From the European Commission to Expand Use of Car T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma

THOMSON REUTERS

Bristol Myers Squibb Receives Approval from the European Commission to Expand Use of CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BMY/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BMY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMY\",,,,,undefined,":{"symbol":"BMY","market":"US","secType":"STK","nameCN":"Bristol-Myers Squibb","latestPrice":47.6,"timestamp":1745501407133,"preClose":48.53,"halted":0,"volume":227715,"delay":0,"floatShares":2030829795,"shares":2034763196,"eps":-4.414405,"marketStatus":"Trading","change":-0.93,"latestTime":"04-24 09:30:11 EDT","open":47.94,"high":47.95,"low":47.6,"amount":10885821.073275,"amplitude":0.007212,"askPrice":47.95,"askSize":176,"bidPrice":47.07,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-4.414405,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1745524800000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":-18475200000,"exchange":"NYSE","adjPreClose":48.53,"dividendRate":0.05084,"preHourTrading":{"tag":"盘前","latestPrice":47.95,"preClose":48.53,"latestTime":"09:29 EDT","volume":106150,"amount":5181374.37455,"timestamp":1745501399999},"postHourTrading":{"tag":"盘后","latestPrice":48.433,"preClose":48.52,"latestTime":"19:59 EDT","volume":433854,"amount":21053683.8714,"timestamp":1745452752933},"volumeRatio":5.767798,"optionData":{"bulkOrders":[{"symbol":"BMY","call":false,"expireDate":1746158400000,"strike":"48.5","timestamp":1745433166567,"price":1.64,"volume":2000,"amount":328000,"type":"-"}]},"impliedVol":0.4254,"impliedVolPercentile":0.9317},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMY\",,,,,undefined,":{"symbol":"BMY","floatShares":2030829795,"roa":"6.55%","roe":"-38.95%","lyrEps":-4.414405,"volumeRatio":14.327614,"shares":2034763196,"dividePrice":2.42,"high":47.95,"amplitude":0.007212,"preClose":48.53,"low":47.6,"week52Low":39.35,"pbRate":"5.94","psRate":"2.01","week52High":63.33,"institutionHeld":0.6798,"latestPrice":47.725,"committee":0.009901,"eps":-4.414405,"divideRate":0.050707,"volume":565660,"delay":0,"ttmEps":-4.414405,"open":47.94,"prevYearClose":56.56,"prevWeekClose":49.23,"prevMonthClose":60.99,"prevQuarterClose":60.99,"fiveDayClose":49.36,"twentyDayClose":59.21,"sixtyDayClose":58.76},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BMY\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2521714287","title":"8 key drug patents expiring soon — and what it means for the market","url":"https://stock-news.laohu8.com/highlight/detail?id=2521714287","media":"Quartz","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521714287?lang=en_us&edition=fundamental","pubTime":"2025-03-24 17:00","pubTimestamp":1742806800,"startTime":"0","endTime":"0","summary":"In this photo illustration, boxes of the diabetes drug Ozempic rest on a pharmacy counter on April 17, 2023 in Los Angeles, California. - Image: Mario Tama / Staff . Nothing drives down a drug’s price like competition. According the U.S. Food and Drug Administration , a drug’s wholesale price drops by an average of 39% after just one generic competitor enters the market. With four generic competitors, prices tumble by 79%. These reductions translate into billions of dollars in savings for American consumers.But before generics can hit the market, a drug’s patent must first expire. In the United States, drug patents last for 20 years from the date a patent application is filed, giving the pharmaceutical company that holds the patent the ability to set the drug’s price without competition during this time.Here are some key drug patents expiring soon.Bristol Myers Squibb and Ono Pharmaceutical’s Opdivo, a treatment for melanoma and other cancers, generated $9;3 billion in global sales. In","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/8-key-drug-patents-expiring-090000809.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BAYRY","JNJ","LU1032466523.USD","LU0820561818.USD","IE00B4R5TH58.HKD","LLY","IE0009355771.USD","LU1506573853.SGD","LU2592432038.USD","LU2505996681.GBP","LU0471298777.SGD","LU1989771016.USD","LU2265009873.SGD","LU1974910355.USD","IE00BDGV0183.EUR","LU2023250504.SGD","SG9999014575.USD","SG9999014906.USD","LU0795875169.SGD","LU1670710588.SGD","AZN","IE00BK4W5L77.USD","LU0256863811.USD","LU2461242641.AUD","LU0208291251.USD","LU0466842654.USD","IE00BK4W5M84.HKD","LU0689472784.USD","LU0109391861.USD","BK4592","LU2242652126.USD","LU0114720955.EUR","LU0345770993.USD","SGXZ57979304.SGD","LU1720051017.SGD","BMY","IE00BLSP4239.USD","LU1551013425.SGD","BK4581","NVO","LU1914381329.SGD","LU1127390331.HKD","PFE","LU0306807586.USD","MRK","GB00BDT5M118.USD","LU1941712264.USD","LU0943347566.SGD","LU2023250843.SGD","LU2491050154.USD"],"gpt_icon":1},{"id":"2521244858","title":"Is Bristol-Myers Squibb (BMY) Among the Cheap Stocks to Buy According to Billionaires?","url":"https://stock-news.laohu8.com/highlight/detail?id=2521244858","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521244858?lang=en_us&edition=fundamental","pubTime":"2025-03-23 04:04","pubTimestamp":1742673883,"startTime":"0","endTime":"0","summary":"We recently published a list of the 15 Best and Cheap Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Bristol-Myers Squibb Company  stands against the other cheap stocks held by billionaires.The S&P 500 index is trading around its all-time high, and the short-term market indicators aren’t much evident with the latest U.S. tariff policy under implementation.Billionaire investor and CEO of Berkshire Hathaway Warren Buffett sold a record $134 billion worth of stock in 2024. Buffett’s move is considered a benchmark among investors to assess the market. Historically, when Buffett’s firm becomes a net seller, it’s often followed by below-average market performance. Many believe that this could be a signal of stock market underperformance in 2025. Cheap stocks held by billionaire investors can be a great option considering the current uncertainty in the market.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bristol-myers-squibb-bmy-among-200443552.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4533","IE00B2B36J28.USD","BK4585","IE0002141913.USD","LU1571399168.USD","BMY","IE00BSNM7G36.USD","LU0742534661.SGD","LU0321505868.SGD","LU0130102774.USD","EC","LU0980610538.SGD","LU1261432733.SGD","LU0096364046.USD","LU2360032135.SGD","LU1291159041.SGD","BK4201","LU1868836591.USD","LU0251131958.USD","IE00BK4W5L77.USD","IE00B3S45H60.SGD","LU1868837136.USD","IE00BFXG1179.USD","LU1868836757.USD","LU0234570918.USD","BK4532","BK4550","LU1718418525.SGD","LU0456855351.SGD","LU1074936037.SGD","LU1430594728.SGD","IE00BJJMRZ35.SGD","LU2133065610.SGD","LU2125154935.USD","LU0648001328.SGD","LU0971096721.USD","LU1670711040.USD","IE00BK4W5M84.HKD","LU1670711123.USD","LU0985481810.HKD","LU1868837300.USD","LU0061475181.USD","LU1093756168.USD","LU0306807586.USD","LU0170899867.USD","LU0787776722.HKD","LU0237698245.USD","LU1363072403.SGD","BK4176"],"gpt_icon":1},{"id":"2521925424","title":"Bristol Myers Squibb Co. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2521925424","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521925424?lang=en_us&edition=fundamental","pubTime":"2025-03-22 04:37","pubTimestamp":1742589420,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Bristol Myers Squibb Co.  advanced 1.08% to $61.07 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.08% to 5,667.56 and the Dow Jones Industrial Average  rising 0.08% to 41,985.35.This was the stock's third consecutive day of gains.Bristol Myers Squibb Co. closed 3.57% below its 52-week high of $63.33, which the company reached on March 11th.The stock outperformed some of its competitors Friday, as Johnson & Johnson  rose 0.37% to $163.63, Pfizer Inc.  rose 0.34% to $26.28, and Abbott Laboratories  fell 0.35% to $126.34.Trading volume  eclipsed its 50-day average volume of 11.6 M.Data source: Dow Jones Market Data, FactSet. Data compiled March 21, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Str","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYE","BMY"],"gpt_icon":0},{"id":"2521233846","title":"Bristol Myers Squibb call volume above normal and directionally bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=2521233846","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521233846?lang=en_us&edition=fundamental","pubTime":"2025-03-21 22:25","pubTimestamp":1742567107,"startTime":"0","endTime":"0","summary":"Bullish option flow detected in Bristol Myers (BMY) Squibb with 11,821 calls trading, 2x expected, and implied vol increasing almost 2 points to 27...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bristol-myers-squibb-call-volume-above-normal-and-directionally-bullish-9?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bristol-myers-squibb-call-volume-above-normal-and-directionally-bullish-9?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BFTCPJ56.SGD","LU1670711123.USD","IE00BJT1NW94.SGD","LU1585245621.USD","IE00B2B36J28.USD","LU1093756168.USD","LU0225771236.USD","MYE","LU1323610961.USD","LU0456855351.SGD","BK4588","LU1868836591.USD","LU1670711040.USD","LU2125154935.USD","LU0306806265.USD","LU2360032135.SGD","LU0321505439.SGD","LU0868494617.USD","LU1670710661.SGD","LU1261432733.SGD","BK4585","IE00BSNM7G36.USD","LU1989771016.USD","LU1291159041.SGD","IE00BJJMRZ35.SGD","BK4126","LU1032466523.USD","LU1868837300.USD","LU2242652126.USD","LU0985481810.HKD","LU1868836757.USD","LU0114720955.EUR","LU2125154778.USD","LU1868837136.USD","LU0237698245.USD","LU1718418525.SGD","LU2133065610.SGD","BK4559","LU0321505868.SGD","BK4532","BMY","LU2242646821.SGD","LU0061475181.USD","LU0306807586.USD","LU1571399168.USD","LU0882574055.USD","LU1670710588.SGD","BK4007","BK4534","LU0225284248.USD"],"gpt_icon":0},{"id":"2521289085","title":"Is VanEck Morningstar Wide Moat ETF (MOAT) a Strong ETF Right Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2521289085","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521289085?lang=en_us&edition=fundamental","pubTime":"2025-03-21 18:20","pubTimestamp":1742552406,"startTime":"0","endTime":"0","summary":"Designed to provide broad exposure to the Style Box - Large Cap Blend category of the market, the VanEck Morningstar Wide Moat ETF  is a smart beta exchange traded fund launched on 04/24/2012.The ETF industry has traditionally been dominated by products based on market capitalization weighted indexes that are designed to represent the market or a particular segment of the market.Market cap weighted indexes offer a low-cost, convenient, and transparent way of replicating market returns, and are a good option for investors who believe in market efficiency.There are some investors, though, who think it's possible to beat the market with great stock selection; this group likely invests in another class of funds known as smart beta, which track non-cap weighted strategies.The fund is sponsored by Van Eck. It has amassed assets over $13.84 billion, making it one of the largest ETFs in the Style Box - Large Cap Blend. MOAT, before fees and expenses, seeks to match the performance of the Morni","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vaneck-morningstar-wide-moat-etf-102006100.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SDS","SPY","LU1868836591.USD","LU1868836914.USD","LU1868836757.USD","BK4524","LU1670710588.SGD","DIS","FDN","LU0310800379.SGD",".SPX","BMY","MORN","LU0237698245.USD","LU0251142724.SGD","LU0029864427.USD","LU1093756168.USD","OEF","SPXU","SSO","LU1585245621.USD","BK4507","LU1894683348.USD","LU2468319806.SGD","SH","BK4583","LU0786609619.USD","LU1718418525.SGD","LU0058720904.USD","ESmain","LU0742534661.SGD","UPRO","VOO","LU0708994859.HKD","LU2133065610.SGD","MOAT","IVV","BK4550","LU0114720955.EUR","LU1670711040.USD","OEX","SG9999015952.SGD","BK4581","LU0321505868.SGD","LU1280957306.USD","IE0002141913.USD","LU1989771016.USD","LU2360032135.SGD","GILD","LU0234570918.USD"],"gpt_icon":1},{"id":"2520451371","title":"2 High-Yield Dividend Stocks That Are Bargain Buys Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2520451371","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520451371?lang=en_us&edition=fundamental","pubTime":"2025-03-20 21:00","pubTimestamp":1742475600,"startTime":"0","endTime":"0","summary":"Pfizer and Bristol Myers Squibb seem to be currently trading at a discount.Both stocks boast high yields, deep pipelines, and robust underlying businesses.They should continue rewarding shareholders with dividend increases in the long run.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/03/20/2-high-yield-dividend-stocks-that-are-bargain-buys/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["BK4585","LU0114720955.EUR","LU2125154935.USD","US7Y.BOND","SG9999013999.USD","LU2125154778.USD","LU0234572021.USD","IE00BSNM7G36.USD","LU1894683348.USD","LU1670710661.SGD","BK4559","US3Y.BOND","BMY","LU0306806265.USD","LU1718418525.SGD","LU0170899867.USD","LU1261432733.SGD","LU0225284248.USD","LU0321505439.SGD","US10Y.BOND","US6M.BOND","SG9999002224.SGD","LU0321505868.SGD","LU1066051498.USD","LU1989771016.USD","LU1023059063.AUD","IE00B19Z3B42.SGD","LU1868837300.USD","LU0289739699.SGD","LU1868836591.USD","US30Y.BOND","PFE","IE0002270589.USD","BK4588","LU1670711123.USD","BK4568","SG9999001176.SGD","BK4550","US2Y.BOND","BK4599","LU0061475181.USD","LU1093756325.SGD","BK4532","LU1066053197.SGD","LU0122379950.USD","LU1883839398.USD","IE0009355771.USD","LU1571399168.USD","US5Y.BOND","US12M.BOND"],"gpt_icon":1},{"id":"2520375119","title":"Bristol Myers Squibb (BMY) Ascends But Remains Behind Market: Some Facts to Note","url":"https://stock-news.laohu8.com/highlight/detail?id=2520375119","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520375119?lang=en_us&edition=fundamental","pubTime":"2025-03-20 05:45","pubTimestamp":1742420714,"startTime":"0","endTime":"0","summary":"Bristol Myers Squibb  closed the latest trading day at $60.08, indicating a +0.3% change from the previous session's end. The stock trailed the S&P 500, which registered a daily gain of 1.08%. On the other hand, the Dow registered a gain of 0.92%, and the technology-centric Nasdaq increased by 1.41%.The biopharmaceutical company's stock has climbed by 10.05% in the past month, exceeding the Medical sector's gain of 0.21% and the S&P 500's loss of 8.26%.The investment community will be closely monitoring the performance of Bristol Myers Squibb in its forthcoming earnings report. The company is scheduled to release its earnings on April 24, 2025. The company is forecasted to report an EPS of $1.55, showcasing a 135.23% upward movement from the corresponding quarter of the prior year. Meanwhile, our latest consensus estimate is calling for revenue of $10.69 billion, down 9.94% from the prior-year quarter.The Zacks Industry Rank gauges the strength of our individual industry groups by meas","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bristol-myers-squibb-bmy-ascends-214514794.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1032466523.USD","IE00BJJMRZ35.SGD","LU0237698245.USD","BK4585","LU2360032135.SGD","LU2242646821.SGD","IE0009355771.USD","LU2125154778.USD","LU1868836591.USD","LU1093756168.USD","LU0096364046.USD","LU0882574055.USD","LU1074936037.SGD","LU1989771016.USD","LU1868836914.USD","IE00BJT1NW94.SGD","LU0456855351.SGD","LU1093756325.SGD","LU1670710588.SGD","BK4559","LU1868837136.USD","LU1868837300.USD","BK4532","LU1291159041.SGD","IE00B2B36J28.USD","LU1571399168.USD","BK4534","LU2242652126.USD","LU1585245621.USD","LU0225771236.USD","LU0114720955.EUR","LU1868836757.USD","BMY","LU2125154935.USD","LU0225284248.USD","BK4581","LU1670711123.USD","IE00BSNM7G36.USD","LU1718418525.SGD","LU1430594728.SGD","LU0306807586.USD","LU0321505868.SGD","BK4007","LU0321505439.SGD","LU0868494617.USD","IE0002141913.USD","IE00BFTCPJ56.SGD","LU2133065610.SGD","LU0061475181.USD","IE00BFXG1179.USD"],"gpt_icon":0},{"id":"2520759066","title":"Actinium Pharmaceuticals Launches Clinical Program to Evaluate Actimab-A as Combination Cancer Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2520759066","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520759066?lang=en_us&edition=fundamental","pubTime":"2025-03-18 20:37","pubTimestamp":1742301422,"startTime":"0","endTime":"0","summary":"Actinium Pharmaceuticals  said Tuesday it is launching a clinical program consisting of trials studying Actimab-A in combination with either Merck's  Keytruda or Bristol Myers Squibb's  Opdivo for the treatment of multiple solid tumors.Actimab-A is meant to improve the efficacy of the immunotherapies by targeting myeloid derived suppressor cells, the company said.The Actimab-A trials will include several controlled, head-to-head studies that will evaluate the combination of Actimab-A with Keytruda and Opdivo in comparison with the two drugs alone.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1430594728.SGD","SG9999015341.SGD","LU1585245621.USD","LU1037948897.HKD","LU2133065610.SGD","LU1868836591.USD","LU1983299246.USD","LU1974910355.USD","BK4588","SG9999014575.USD","LU1670710588.SGD","BK4532","BK4581","ATNM","LU0321505868.SGD","LU0965509101.SGD","IE00BFXG1179.USD","LU1989772840.SGD","LU2242646821.SGD","LU0203345920.USD","SG9999002224.SGD","IE00BFTCPJ56.SGD","LU2112291526.USD","BMY","LU0114720955.EUR","LU0203347892.USD","BK4585","IE00BLSP4239.USD","IE00BN8TJ469.HKD","MRK","LU0234572021.USD","LU1066053197.SGD","LU1069347547.HKD","LU2106854487.HKD","SG9999002232.USD","LU0321505439.SGD","LU0225771236.USD","LU1670710661.SGD","LU2461242641.AUD","IE0002141913.USD","LU1066051225.USD","LU1116320901.HKD","LU2324357040.USD","LU1934455863.HKD","LU1261432733.SGD","LU0061475181.USD","SGXZ57979304.SGD","LU0237698245.USD","LU1934455277.USD","LU2360032135.SGD"],"gpt_icon":0},{"id":"2520887066","title":"Bristol-Myers Squibb Company (BMY): A Bull Case Theory","url":"https://stock-news.laohu8.com/highlight/detail?id=2520887066","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520887066?lang=en_us&edition=fundamental","pubTime":"2025-03-18 01:35","pubTimestamp":1742232900,"startTime":"0","endTime":"0","summary":"We came across abullish thesison Bristol-Myers Squibb Company  on Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on BMY. Bristol-Myers Squibb Company 's share was trading at $59.01 as of March 16th. BMY’s trailing and forward P/E were 22.79 and 8.73 respectively according to Yahoo Finance.Bristol-Myers Squibb  presents a compelling yet high-stakes investment opportunity as it navigates a pivotal transition in its product portfolio. The company's current valuation reflects market skepticism regarding its ability to offset revenue declines from legacy drugs facing patent expirations. However, BMY’s growth strategy hinges on a series of promising new treatments, particularly its neuroscience drug Cobenfy, which could redefine the company’s financial trajectory if it delivers positive trial results.Investors must recognize the risks associated with BMY’s current position. While the company has a robust pipeline, its near-term performance is disproportionate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bristol-myers-squibb-company-bmy-173500995.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4532","LU0456855351.SGD","LU2133065610.SGD","BK4007","LU1074936037.SGD","LU2360032135.SGD","LU1670710661.SGD","LU2125154935.USD","IE00BFTCPJ56.SGD","LU1571399168.USD","LU1868836914.USD","LU1585245621.USD","LU0096364046.USD","LU1868837136.USD","LU0306806265.USD","LU1291159041.SGD","LU0306807586.USD","BMY","IE0002141913.USD","LU0985481810.HKD","LU0061475181.USD","LU1670710588.SGD","LU2242652126.USD","LU0868494617.USD","IE00B2B36J28.USD","LU1868837300.USD","LU2242646821.SGD","IE00BSNM7G36.USD","BK4534","IE0009355771.USD","LU0225284248.USD","IE00BJT1NW94.SGD","LU1670711123.USD","IE00BJJMRZ35.SGD","BK4581","LU0882574055.USD","LU1032466523.USD","LU1989771016.USD","LU1093756325.SGD","LU0321505439.SGD","LU2125154778.USD","LU1868836757.USD","LU0237698245.USD","LU0114720955.EUR","LU1261432733.SGD","LU1718418525.SGD","LU1323610961.USD","BK4559","LU0321505868.SGD","IE00BFXG1179.USD"],"gpt_icon":0},{"id":"2520735544","title":"Perspective Therapeutics Starts Dosing New Cohort for Melanoma Tumor Treatment Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2520735544","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520735544?lang=en_us&edition=fundamental","pubTime":"2025-03-17 19:36","pubTimestamp":1742211417,"startTime":"0","endTime":"0","summary":"Perspective Therapeutics (CATX) said Monday the first patient was dosed in a new cohort of its phase 1/2a trial evaluating the safety of targeted alpha-particle therapy [212Pb]VMT01 in patients with h","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1718418525.SGD","LU2242646821.SGD","LU1989771016.USD","LU0321505439.SGD","BK4534","BK4139","LU1670711123.USD","LU2360032135.SGD","IE00BFTCPJ56.SGD","LU2125154778.USD","LU1430594728.SGD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU1868836757.USD","LU1291159041.SGD","LU1670711040.USD","BK4532","LU0114720955.EUR","LU0868494617.USD","LU0225284248.USD","BK4585","LU1074936037.SGD","LU2133065610.SGD","LU1868837136.USD","CATX","LU1868836591.USD","LU1670710661.SGD","IE00BFXG1179.USD","LU2125154935.USD","LU1585245621.USD","IE0002141913.USD","LU0985481810.HKD","LU0306807586.USD","LU1571399168.USD","BK4559","IE00B2B36J28.USD","BK4007","BK4588","LU0096364046.USD","LU0456855351.SGD","IE0009355771.USD","IE00BSNM7G36.USD","BMY","LU1261432733.SGD","LU0061475181.USD","LU1093756325.SGD","LU1323610961.USD","LU0237698245.USD","LU0321505868.SGD","LU1093756168.USD"],"gpt_icon":0},{"id":"2519556273","title":"BRIEF-CMS Announces Manufacturer Participation in Second Cycle of Medicare Drug Price Negotiation","url":"https://stock-news.laohu8.com/highlight/detail?id=2519556273","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519556273?lang=en_us&edition=fundamental","pubTime":"2025-03-15 05:56","pubTimestamp":1741989411,"startTime":"0","endTime":"0","summary":"BRIEF-CMS Announces Manufacturer Participation in Second Cycle of Medicare Drug Price NegotiationMarch 14  - CMS: DEALS SIGNED WITH MANUFACTURERS OF 15 DRUGS COVERED UNDER MEDICARE PART D SELECTED FOR SECOND CYCLE OF MEDICARE DRUG PRICE NEGOTIATION PROGRAM ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250314:nFWN3PX0R5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1162221912.USD","MRK","LU1035773651.USD","03165","LU1496350171.SGD","LU0965508806.USD","LU1894683348.USD","ABBV","LU0058720904.USD","LU2091194634.USD","LU1098665638.USD","IE0002270589.USD","GSK.UK","LU2237443382.USD","LU1732800096.USD","IE00B42XCP33.USD","BK4007","LU1670710661.SGD","IE00BN8TJ469.HKD","SG9999014559.SGD","LU0823399737.USD","LU0047473722.EUR","IE00BWDBJ516.SGD","IE00BFTCPJ56.SGD","LU1228905540.USD","LU1015430645.USD","LU0211326755.USD","AMGN","LU1941712348.USD","LU0456855351.SGD","LU1814569148.SGD","AZN.UK","LU0738911758.USD","LU2242652126.USD","LU0265550359.USD","BMY","SG9999014575.USD","LU2089284900.SGD","BK4516","LU0306806265.USD","LU1116320737.USD","LU0889566641.SGD","BK4568","LU0795875086.SGD","LU0661504455.SGD","SGXZ57979304.SGD","LU2237443622.USD","LU1917777945.USD","LU0949170772.SGD"],"gpt_icon":0},{"id":"2519606337","title":"Bristol Myers Squibb Co. Stock Underperforms Friday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2519606337","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519606337?lang=en_us&edition=fundamental","pubTime":"2025-03-15 04:36","pubTimestamp":1741984560,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Bristol Myers Squibb Co.  slipped 2.11% to $59.01 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 2.13% to 5,638.94 and the Dow Jones Industrial Average  rising 1.65% to 41,488.19.Bristol Myers Squibb Co. closed 6.82% below its 52-week high of $63.33, which the company reached on March 11th.The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson  fell 0.11% to $162.81, Pfizer Inc.  rose 0.47% to $25.72, and Abbott Laboratories  fell 2.45% to $126.71.Data source: Dow Jones Market Data, FactSet. Data compiled March 14, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMY","MYE"],"gpt_icon":0},{"id":"2519933180","title":"BUZZ - S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT","url":"https://stock-news.laohu8.com/highlight/detail?id=2519933180","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519933180?lang=en_us&edition=fundamental","pubTime":"2025-03-15 03:30","pubTimestamp":1741980618,"startTime":"0","endTime":"0","summary":"BUZZ - S&P 500 top and bottom performing stocks at about 03:30 p.m. EDTS&P 500 .SPXTop PerformersPercent ChangeUlta Beauty Inc ULTA.OQ+13.7%Crown Castle Inc CCI.N+10.2%Palantir Technologies Inc PLTR.OQ+8.8%Celanese Corp CE.N+7.5%Super Micro Computer Inc SMCI.OQ+6.8%Bottom PerformersPercent ChangeAbbott Laboratories ABT.N-2.8%Bristol-Myers Squibb Co BMY.N-2.3%Dollar Tree Inc DLTR.OQ-2.3%Kroger Co KR.N-2.2%Kenvue Inc KVUE.N-1.9%As of 03:30 p.m., the S&P 500 .SPX gained 104.31 points, or 1.88%, to 5,625.83 and had posted one new 52-week high and 5 new lows.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250314:nL8N3PX1ZF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGXZ23171101.USD","LU0061475181.USD","LU1914381329.SGD","BK4592","LU0053671581.USD","CCI","BK4515","KVUE","LU0006061336.USD","KR","SG9999002224.SGD","PLTR","LU0122379950.USD","LU1718418525.SGD","ABT","BK4566","IE0009355771.USD","DLTR","LU0237698245.USD","BK4113","LU0321505439.SGD","LU0345770308.USD","LU0302445910.USD","BK4533","BK4504","IE00BJT1NW94.SGD","LU0456855351.SGD","LU1323610961.USD","LU1868837136.USD","LU0792757196.USD","LU2125154778.USD","BMY","BK4568","LU0345770993.USD","LU1861558580.USD","ULTA","LU0980610538.SGD","LU0985481810.HKD","LU1861220033.SGD","LU2275660780.HKD","LU1074936037.SGD","CE","LU1057294990.SGD","LU0225284248.USD","LU1868836914.USD","IE00BFTCPJ56.SGD","IE00BSNM7G36.USD","SG9999004303.SGD","LU1093756168.USD"],"gpt_icon":1},{"id":"2519338297","title":"Bristol-Myers Squibb (NYSE:BMY) Gets EC Nod For Breyanzi In NHL Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2519338297","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519338297?lang=en_us&edition=fundamental","pubTime":"2025-03-15 01:27","pubTimestamp":1741973244,"startTime":"0","endTime":"0","summary":"Bristol-Myers Squibb recently gained European Commission approval for Breyanzi, broadening treatment options for indolent non-Hodgkin lymphoma, which was a significant recent event. During the last quarter, the company's stock rose by 8%, amid a backdrop of several key events and broader market trends. Positive results from the Phase 3 POETYK PsA-2 trial for Sotyktu and a substantial share buyback program may have bolstered investor confidence. Additionally, a quarterly dividend declaration continued to assure income-oriented investors. On a broader scale, market activity demonstrated volatility; however, the technology sector experienced a rally, and the Dow Jones Industrial Average rebounded, signaling a partial market recovery following a correction phase. These factors contributed to Bristol-Myers Squibb's share performance, as the company navigated a challenging but promising landscape with strategic product approvals and shareholder-focused actions.Gain insight into the risks fac","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bristol-myers-squibb-nyse-bmy-172724887.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0061475181.USD","IE00BJT1NW94.SGD","LU0096364046.USD","LU0868494617.USD","IE00BFTCPJ56.SGD","LU0882574055.USD","LU2242646821.SGD","LU2133065610.SGD","LU1868837300.USD","NYSE","LU1868836591.USD","LU1868836757.USD","LU0114720955.EUR","BK4585","BK4201","LU1323610961.USD","BK4581","LU0985481810.HKD","IE00BSNM7G36.USD","LU0306807586.USD","LU2360032135.SGD","LU0225284248.USD","BK4588","LU1261432733.SGD","EC","LU1093756168.USD","LU1430594728.SGD","LU1585245621.USD","LU1670711040.USD","LU2125154935.USD","BK4534","LU1670711123.USD","LU1868837136.USD","BK4559","LU0321505439.SGD","LU1291159041.SGD","IE00BFXG1179.USD","BMY","LU2242652126.USD","IE00B2B36J28.USD","LU2125154778.USD","BK4007","LU1670710588.SGD","LU0306806265.USD","IE0002141913.USD","BK4532","LU0456855351.SGD","LU0237698245.USD","IE00BJJMRZ35.SGD","LU1032466523.USD"],"gpt_icon":0},{"id":"2519806068","title":"Bristol-Myers Squibb Says EU Approves Breyanzi for Relapsed, Refractory Follicular Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2519806068","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519806068?lang=en_us&edition=fundamental","pubTime":"2025-03-14 20:44","pubTimestamp":1741956273,"startTime":"0","endTime":"0","summary":"Bristol-Myers Squibb (BMY) said Friday that Breyanzi has received approval from the European Commission for the treatment of adult patients with relapsed or refractory follicular lymphoma.The addition","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0096364046.USD","LU2242646821.SGD","BK4156","LU1032466523.USD","LU1430594728.SGD","LU1291159041.SGD","LU0306807586.USD","LU1670711123.USD","LU1670710588.SGD","BK4559","LU1093756168.USD","LU2242652126.USD","BK4534","LU0225284248.USD","BK4532","LU0306806265.USD","LU1989771016.USD","LU0985481810.HKD","LU0237698245.USD","LU0321505439.SGD","LU2133065610.SGD","IE00BFXG1179.USD","BK4007","LU0321505868.SGD","LU0061475181.USD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","LU1868836757.USD","LU2125154778.USD","LU0456855351.SGD","BMY","BK4588","LU1868837300.USD","LU0882574055.USD","LU2360032135.SGD","LU0868494617.USD","IE0009355771.USD","IE00BSNM7G36.USD","IE00BFTCPJ56.SGD","LU2125154935.USD","IE0002141913.USD","LU1093756325.SGD","IE00BJT1NW94.SGD","LU1718418525.SGD","LU0225771236.USD","LU1261432733.SGD","LU1670710661.SGD","BK4581","LU1571399168.USD"],"gpt_icon":0},{"id":"2519254877","title":"Bristol Myers Gets Expanded European Approval for Breyanzi","url":"https://stock-news.laohu8.com/highlight/detail?id=2519254877","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519254877?lang=en_us&edition=fundamental","pubTime":"2025-03-14 19:16","pubTimestamp":1741950960,"startTime":"0","endTime":"0","summary":"Bristol Myers Squibb has won European Commission expanded approval of its CAR-T cell therapy Breyanzi in the blood cancer lymphoma.The Princeton, N.J., biopharmaceutical company on Friday said the approval covers Breyanzi for the treatment of adults with relapsed or refractory follicular lymphoma who have received two or more prior lines of systemic therapy.Breyanzi, which was already approved in several lymphoma indications in Europe, generated worldwide revenue of $747 million last year.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYE","BK4126","BMY"],"gpt_icon":0},{"id":"2519872049","title":"Bristol Myers announces EC approval of Breyanzi","url":"https://stock-news.laohu8.com/highlight/detail?id=2519872049","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519872049?lang=en_us&edition=fundamental","pubTime":"2025-03-14 19:06","pubTimestamp":1741950373,"startTime":"0","endTime":"0","summary":"Bristol Myers (BMY) Squibb announced that the European Commission has granted approval to Breyanzi, a CD19-directed chimeric antigen receptor T cel...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bristol-myers-announces-ec-approval-of-breyanzi?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bristol-myers-announces-ec-approval-of-breyanzi?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1868836757.USD","LU1585245621.USD","LU2133065610.SGD","LU1868836591.USD","BK4201","BK4588","LU0868494617.USD","LU2242652126.USD","LU1670710588.SGD","LU1868837136.USD","LU0306806265.USD","BK4532","BK4581","IE00BSNM7G36.USD","LU0321505868.SGD","IE00BFXG1179.USD","LU2242646821.SGD","LU1323610961.USD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","BMY","LU0114720955.EUR","LU0306807586.USD","LU1571399168.USD","BK4585","LU2125154778.USD","LU1670711123.USD","LU0985481810.HKD","LU1291159041.SGD","BK4534","EC","LU0321505439.SGD","LU0225771236.USD","LU1670710661.SGD","IE0002141913.USD","LU2125154935.USD","LU1718418525.SGD","MYE","BK4559","BK4126","LU1261432733.SGD","LU1670711040.USD","LU1868836914.USD","LU0237698245.USD","LU1868837300.USD","LU1093756325.SGD","LU1093756168.USD","LU0882574055.USD","LU2360032135.SGD","LU1074936037.SGD"],"gpt_icon":0},{"id":"2519872412","title":"BRIEF-Bristol Myers Squibb Receives Approval From The European Commission To Expand Use Of Car T Cell Therapy Breyanzi For Relapsed Or Refractory Follicular Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2519872412","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519872412?lang=en_us&edition=fundamental","pubTime":"2025-03-14 19:03","pubTimestamp":1741950215,"startTime":"0","endTime":"0","summary":"BRIEF-Bristol Myers Squibb Receives Approval From The European Commission To Expand Use Of Car T Cell Therapy Breyanzi For Relapsed Or Refractory Follicular LymphomaMarch 14 (Reuters) - Bristol-Myers ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250314:nFWN3PX0CS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2360032135.SGD","LU0306807586.USD","IE0009355771.USD","LU2242652126.USD","LU1093756325.SGD","BK4532","LU1718418525.SGD","LU1868837136.USD","IE00B2B36J28.USD","LU0985481810.HKD","LU2133065610.SGD","LU2125154935.USD","IE0002141913.USD","IE00BJJMRZ35.SGD","LU0114720955.EUR","LU1291159041.SGD","LU1571399168.USD","LU1670710588.SGD","LU1032466523.USD","LU1670711123.USD","LU2242646821.SGD","LU0225771236.USD","LU0225284248.USD","LU1261432733.SGD","IE00BSNM7G36.USD","LU0882574055.USD","BK4559","LU0061475181.USD","LU1430594728.SGD","LU1323610961.USD","LU1868837300.USD","LU1670711040.USD","LU1868836591.USD","LU1093756168.USD","LU1868836757.USD","LU1585245621.USD","LU0096364046.USD","LU0306806265.USD","IE00BFTCPJ56.SGD","BK4534","LU1670710661.SGD","LU0868494617.USD","LU0456855351.SGD","LU1074936037.SGD","BMY","BK4581","BK4007","LU0237698245.USD","LU0321505439.SGD","LU1989771016.USD"],"gpt_icon":1},{"id":"2519386872","title":"Bristol Myers Squibb Receives Approval From the European Commission to Expand Use of Car T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2519386872","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519386872?lang=en_us&edition=fundamental","pubTime":"2025-03-14 18:59","pubTimestamp":1741949944,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250314:nFWN3PX0CS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2242646821.SGD","IE00B2B36J28.USD","LU1868836757.USD","BK4559","LU1868837136.USD","LU1989771016.USD","BK4588","LU0456855351.SGD","LU0306806265.USD","BK4534","IE00BJT1NW94.SGD","LU1032466523.USD","LU1670710588.SGD","LU0061475181.USD","BMY","LU0114720955.EUR","IE0009355771.USD","LU1868836591.USD","LU0321505439.SGD","LU0237698245.USD","BK4581","LU0225284248.USD","LU0985481810.HKD","LU1868836914.USD","LU1670710661.SGD","IE0002141913.USD","LU1571399168.USD","LU1718418525.SGD","IE00BSNM7G36.USD","IE00BFXG1179.USD","BK4585","LU1670711040.USD","LU2242652126.USD","LU2360032135.SGD","BK4532","LU2125154778.USD","LU1093756168.USD","IE00BJJMRZ35.SGD","LU2125154935.USD","LU1670711123.USD","LU2133065610.SGD","LU1074936037.SGD","LU1261432733.SGD","LU0306807586.USD","LU0868494617.USD","LU0096364046.USD","LU1093756325.SGD","LU1430594728.SGD","BK4007","IE00BFTCPJ56.SGD"],"gpt_icon":0},{"id":"2519808851","title":"Bristol Myers Squibb Receives Approval from the European Commission to Expand Use of CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2519808851","media":"Business Wire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519808851?lang=en_us&edition=fundamental","pubTime":"2025-03-14 18:59","pubTimestamp":1741949940,"startTime":"0","endTime":"0","summary":"In the TRANSCEND FL trial, 97.1% of patients responded to Breyanzi, with 94.2% of patients achieving complete response*. Breyanzi demonstrated sustained clinical benefit, with 75.7% of patients still in response at 18 months, and a consistent safety profile with no new safety signals observed. PRINCETON, N.J., March 14, 2025----Bristol Myers Squibb  today announced that the European Commission  has granted approval to Breyanzi , a CD19-directed chimeric antigen receptor  T cell therapy, for the treatment of adult patients with relapsed or refractory follicular lymphoma  after two or more lines of systemic therapy.This expanded approval is applicable to all European Union  member states as well as the European Economic Area  countries Iceland, Norway and Liechtenstein.** Breyanzi is also approved in the EU for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma , high grade B-cell lymphoma , primary mediastinal large B-cell lymphoma  and FL grade 3B","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bristol-myers-squibb-receives-approval-105900919.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2360032135.SGD","BK4201","LU1670711040.USD","LU0114720955.EUR","CAR","LU0096364046.USD","LU1093756325.SGD","BK4230","BK4094","LU2133065610.SGD","BK4588","IE00BFXG1179.USD","CRS","BK4528","IE00B66KJ199.SGD","LU2242646821.SGD","LU1261432733.SGD","IE0031619046.USD","BK4205","EEA","FL","LU0882574055.USD","BK4534","BK4156","LU2125154778.USD","LU0237698245.USD","BK4585","LU0225771236.USD","MYE","BMY","IE00BFTCPJ56.SGD","LU0061475181.USD","LU0306806265.USD","LU2242652126.USD","LU0456855351.SGD","LU2125154935.USD","UK","LU1323610961.USD","EC","LU1430594728.SGD","LU0868494617.USD","LU1032466523.USD","LU2065731478.USD","LU1718418525.SGD","IE00BSNM7G36.USD","LU1585245621.USD","CR","IE00BJJMRZ35.SGD","HSCT"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BMY\",params:#limit:5,,,undefined,":[{"date":"2025-04-24","symbol":"BMY","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":1.51,"defaultRemindTime":1745481600000,"name":null,"time":"Pre-Market","dateTimestamp":1745467200000,"actualEps":null},{"date":"2025-04-04","symbol":"BMY","amount":0.62,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-04","defaultRemindTime":1743773400000,"name":"施贵宝","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-01","payableDate":"2025-04-04","currency":"USD","dateTimestamp":1743739200000,"payDate":"2025-05-01"},{"market":"US","date":"2025-02-06","symbol":"BMY","fiscalQuarterEnding":"2024/12","expectedEps":1.46,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1738818000000,"reportTimeType":"pre","actualEps":1.67},{"date":"2025-01-03","symbol":"BMY","amount":0.62,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-01-03","defaultRemindTime":1735914600000,"name":"施贵宝","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-02-03","payableDate":"2025-01-03","currency":"USD","dateTimestamp":1735880400000,"payDate":"2025-02-03"},{"market":"US","date":"2024-10-31","symbol":"BMY","fiscalQuarterEnding":"2024/09","expectedEps":1.49,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730347200000,"reportTimeType":"pre","actualEps":1.8}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BMY\",market:\"US\",,,undefined,":[{"executeDate":"2015-07-01","recordDate":"2015-07-06","paymentDate":"2015-08-03","value":0.37,"currency":"USD"},{"executeDate":"2015-09-30","recordDate":"2015-10-02","paymentDate":"2015-11-02","value":0.37,"currency":"USD"},{"executeDate":"2015-12-30","recordDate":"2016-01-04","paymentDate":"2016-02-01","value":0.38,"currency":"USD"},{"executeDate":"2016-03-30","recordDate":"2016-04-01","paymentDate":"2016-05-02","value":0.38,"currency":"USD"},{"executeDate":"2016-06-29","recordDate":"2016-07-01","paymentDate":"2016-08-01","value":0.38,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BMY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1071,"buy":0.1429,"hold":0.6786,"sell":0.0714,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.6786,"analysts":28,"updateTime":1745380800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BMY\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BMY","date":"2025-04-23","current":-11.329001,"percent":0.49147,"low":-3427.632189,"twenty":-24.204041,"median":12.060673,"eighty":23.368181,"high":152.008162,"avg":-163.35942,"sd":702.1657,"marketCap":101371902424},"quantilePoints":[{"date":"2020-04-24","current":40.953284,"twenty":26.163897,"median":40.595255,"eighty":57.731222,"marketCap":140838343724},{"date":"2020-05-01","current":39.644095,"twenty":26.163897,"median":40.646079,"eighty":57.731222,"marketCap":136336041651},{"date":"2020-05-08","current":144.797914,"twenty":26.163897,"median":40.716632,"eighty":57.780539,"marketCap":138137209542},{"date":"2020-05-15","current":152.008162,"twenty":26.163897,"median":40.828913,"eighty":58.028862,"marketCap":145015786397},{"date":"2020-05-22","current":144.181248,"twenty":26.163897,"median":40.989755,"eighty":58.258767,"marketCap":137548910206},{"date":"2020-05-29","current":141.64343,"twenty":26.163897,"median":41.152517,"eighty":58.434572,"marketCap":135127832168},{"date":"2020-06-05","current":145.462015,"twenty":26.163897,"median":41.507602,"eighty":58.543425,"marketCap":138770762674},{"date":"2020-06-12","current":133.223568,"twenty":26.163897,"median":41.630405,"eighty":58.70227,"marketCap":127095283538},{"date":"2020-06-19","current":133.792798,"twenty":26.163897,"median":41.779831,"eighty":59.065322,"marketCap":127638329079},{"date":"2020-06-26","current":136.472923,"twenty":26.163897,"median":41.955835,"eighty":59.303982,"marketCap":130195168502},{"date":"2020-07-02","current":140.26779,"twenty":26.163897,"median":42.192232,"eighty":59.612319,"marketCap":133815472110},{"date":"2020-07-10","current":136.212026,"twenty":26.163897,"median":42.354947,"eighty":59.954728,"marketCap":129946272629},{"date":"2020-07-17","current":143.232531,"twenty":26.163897,"median":42.505381,"eighty":60.343483,"marketCap":136643834304},{"date":"2020-07-24","current":137.208179,"twenty":26.163897,"median":42.754058,"eighty":60.719618,"marketCap":130896602326},{"date":"2020-07-31","current":139.12933,"twenty":26.163897,"median":43.2132,"eighty":60.965815,"marketCap":132729381028},{"date":"2020-08-07","current":-244.289683,"twenty":26.104809,"median":43.30835,"eighty":63.241479,"marketCap":137535091427},{"date":"2020-08-14","current":-252.857036,"twenty":25.671207,"median":43.30835,"eighty":63.241479,"marketCap":142358511546},{"date":"2020-08-21","current":-248.973703,"twenty":24.738199,"median":43.30835,"eighty":63.241479,"marketCap":140172194950},{"date":"2020-08-28","current":-249.694322,"twenty":24.53695,"median":43.30835,"eighty":63.241479,"marketCap":140577903184},{"date":"2020-09-04","current":-240.006006,"twenty":24.217273,"median":43.30835,"eighty":63.241479,"marketCap":135123381368},{"date":"2020-09-11","current":-236.162707,"twenty":23.958745,"median":43.30835,"eighty":63.241479,"marketCap":132959604118},{"date":"2020-09-18","current":-237.283669,"twenty":23.923139,"median":43.30835,"eighty":63.241479,"marketCap":133590705816},{"date":"2020-09-25","current":-238.164425,"twenty":23.703169,"median":43.30835,"eighty":63.241479,"marketCap":134086571436},{"date":"2020-10-02","current":-235.081779,"twenty":23.363915,"median":43.30835,"eighty":63.241479,"marketCap":132351041767},{"date":"2020-10-09","current":-247.492432,"twenty":17.593463,"median":43.30835,"eighty":63.241479,"marketCap":139338239135},{"date":"2020-10-16","current":-245.170439,"twenty":17.05085,"median":43.30835,"eighty":63.241479,"marketCap":138030957047},{"date":"2020-10-23","current":-240.726625,"twenty":16.915253,"median":43.30835,"eighty":63.241479,"marketCap":135529089602},{"date":"2020-10-30","current":-234.000852,"twenty":16.878905,"median":43.30835,"eighty":63.241479,"marketCap":131742479415},{"date":"2020-11-06","current":-3276.639701,"twenty":16.797113,"median":43.30835,"eighty":63.241479,"marketCap":144172146848},{"date":"2020-11-13","current":-3267.395263,"twenty":16.644024,"median":43.30835,"eighty":63.241479,"marketCap":143765391575},{"date":"2020-11-20","current":-3164.165705,"twenty":16.603263,"median":43.30835,"eighty":63.241479,"marketCap":139223291023},{"date":"2020-11-27","current":-3238.121209,"twenty":16.551974,"median":43.30835,"eighty":63.241479,"marketCap":142477333209},{"date":"2020-12-04","current":-3200.116297,"twenty":16.449584,"median":43.30835,"eighty":63.241479,"marketCap":140805117086},{"date":"2020-12-11","current":-3118.457095,"twenty":16.271128,"median":43.30835,"eighty":63.241479,"marketCap":137212112172},{"date":"2020-12-18","current":-3241.716269,"twenty":16.177691,"median":43.24944,"eighty":63.241479,"marketCap":142635515816},{"date":"2020-12-24","current":-3140.54103,"twenty":15.969441,"median":43.24944,"eighty":63.241479,"marketCap":138183805325},{"date":"2020-12-31","current":-3185.73606,"twenty":15.745139,"median":43.24944,"eighty":63.241479,"marketCap":140172386661},{"date":"2021-01-08","current":-3209.360735,"twenty":15.520794,"median":43.24944,"eighty":63.241479,"marketCap":141211872359},{"date":"2021-01-15","current":-3417.360591,"twenty":15.454453,"median":43.24944,"eighty":63.241479,"marketCap":150363866007},{"date":"2021-01-22","current":-3315.671773,"twenty":15.292279,"median":43.24944,"eighty":63.241479,"marketCap":145889558002},{"date":"2021-01-29","current":-3154.921267,"twenty":15.193414,"median":43.24944,"eighty":63.241479,"marketCap":138816535750},{"date":"2021-02-05","current":-15.270556,"twenty":15.111639,"median":43.24944,"eighty":63.241479,"marketCap":137664062476},{"date":"2021-02-12","current":-14.909163,"twenty":15.037512,"median":43.24944,"eighty":63.241479,"marketCap":134406104428},{"date":"2021-02-19","current":-15.060765,"twenty":14.994264,"median":43.24944,"eighty":63.241479,"marketCap":135772794271},{"date":"2021-02-26","current":-15.24219,"twenty":14.895142,"median":43.24944,"eighty":63.241479,"marketCap":137408341133},{"date":"2021-03-05","current":-15.018515,"twenty":14.827729,"median":43.252713,"eighty":64.853776,"marketCap":135391913495},{"date":"2021-03-12","current":-15.070706,"twenty":14.750073,"median":43.252713,"eighty":64.853776,"marketCap":135862413277},{"date":"2021-03-19","current":-15.582672,"twenty":14.671279,"median":43.252713,"eighty":64.853776,"marketCap":140477792093},{"date":"2021-03-26","current":-15.84441,"twenty":14.611498,"median":43.24944,"eighty":63.241479,"marketCap":142837352227},{"date":"2021-04-01","current":-15.59413,"twenty":14.591649,"median":43.24944,"eighty":63.241479,"marketCap":140581085012},{"date":"2021-04-09","current":-15.514834,"twenty":14.520487,"median":43.252713,"eighty":64.853776,"marketCap":139866228072},{"date":"2021-04-16","current":-16.221067,"twenty":14.424522,"median":43.252713,"eighty":64.853776,"marketCap":146232922690},{"date":"2021-04-23","current":-16.357358,"twenty":14.234366,"median":43.246167,"eighty":64.853776,"marketCap":147461583055},{"date":"2021-04-30","current":-22.411016,"twenty":14.031315,"median":41.99272,"eighty":64.853776,"marketCap":139374107187},{"date":"2021-05-07","current":-23.136268,"twenty":13.765653,"median":40.725784,"eighty":64.853776,"marketCap":143884451572},{"date":"2021-05-14","current":-23.294244,"twenty":13.598846,"median":40.216454,"eighty":64.853776,"marketCap":144866902824},{"date":"2021-05-21","current":-24.073352,"twenty":13.387812,"median":39.861196,"eighty":64.853776,"marketCap":149712173772},{"date":"2021-05-28","current":-23.595834,"twenty":13.305536,"median":39.584885,"eighty":64.853776,"marketCap":146742491578},{"date":"2021-06-04","current":-23.315786,"twenty":13.183703,"median":39.110931,"eighty":64.853776,"marketCap":145000873449},{"date":"2021-06-11","current":-24.177472,"twenty":13.076111,"median":38.321748,"eighty":64.853776,"marketCap":150359698461},{"date":"2021-06-18","current":-23.865111,"twenty":12.918943,"median":37.341182,"eighty":64.853776,"marketCap":148417124394},{"date":"2021-06-25","current":-23.962051,"twenty":12.713253,"median":37.032625,"eighty":64.853776,"marketCap":149019992208},{"date":"2021-07-02","current":-24.037448,"twenty":12.656819,"median":36.735495,"eighty":64.853776,"marketCap":149488889397},{"date":"2021-07-09","current":-24.112846,"twenty":12.542371,"median":36.569788,"eighty":64.853776,"marketCap":149957786585},{"date":"2021-07-16","current":-24.163111,"twenty":12.276028,"median":36.398367,"eighty":64.853776,"marketCap":150270384711},{"date":"2021-07-23","current":-24.536508,"twenty":12.058207,"median":36.20409,"eighty":64.853776,"marketCap":152592542216},{"date":"2021-07-30","current":-29.693807,"twenty":11.96591,"median":36.009813,"eighty":61.057,"marketCap":150814846842},{"date":"2021-08-06","current":-29.803185,"twenty":-14.753585,"median":35.906961,"eighty":60.876911,"marketCap":151370375230},{"date":"2021-08-13","current":-29.536304,"twenty":-14.987324,"median":35.781252,"eighty":60.876911,"marketCap":150014885963},{"date":"2021-08-20","current":-30.275696,"twenty":-15.059273,"median":34.627419,"eighty":60.876911,"marketCap":153770257867},{"date":"2021-08-27","current":-29.138169,"twenty":-15.115938,"median":34.17561,"eighty":60.876911,"marketCap":147992762629},{"date":"2021-09-03","current":-28.705034,"twenty":-15.248154,"median":33.35279,"eighty":60.876911,"marketCap":145792870212},{"date":"2021-09-10","current":-27.62001,"twenty":-15.348311,"median":32.979745,"eighty":60.876911,"marketCap":140282028600},{"date":"2021-09-17","current":-26.823741,"twenty":-15.441509,"median":32.518541,"eighty":60.876911,"marketCap":136237781934},{"date":"2021-09-24","current":-26.35123,"twenty":-15.542928,"median":32.364263,"eighty":60.876911,"marketCap":133837899297},{"date":"2021-10-01","current":-26.036223,"twenty":-15.613954,"median":32.061419,"eighty":60.876911,"marketCap":132237977539},{"date":"2021-10-08","current":-25.051826,"twenty":-15.777999,"median":31.581441,"eighty":60.876911,"marketCap":127238222044},{"date":"2021-10-15","current":-25.533087,"twenty":-16.234944,"median":30.750116,"eighty":60.876911,"marketCap":129682546953},{"date":"2021-10-22","current":-25.200579,"twenty":-16.36727,"median":30.429194,"eighty":60.876911,"marketCap":127993740652},{"date":"2021-10-29","current":-23.982843,"twenty":-22.664495,"median":30.34167,"eighty":60.876911,"marketCap":129627264204},{"date":"2021-11-05","current":-24.414041,"twenty":-23.13914,"median":30.156897,"eighty":60.876911,"marketCap":131957891385},{"date":"2021-11-12","current":-24.405828,"twenty":-23.227463,"median":30.035336,"eighty":60.876911,"marketCap":131913498487},{"date":"2021-11-19","current":-23.748763,"twenty":-23.330148,"median":29.933224,"eighty":60.876911,"marketCap":128362066591},{"date":"2021-11-26","current":-23.214899,"twenty":-23.393674,"median":29.797076,"eighty":60.876911,"marketCap":125476528175},{"date":"2021-12-03","current":-23.128659,"twenty":-23.393674,"median":29.729002,"eighty":60.876911,"marketCap":125010402739},{"date":"2021-12-10","current":-23.145086,"twenty":-23.461298,"median":29.636615,"eighty":60.876911,"marketCap":125099188536},{"date":"2021-12-17","current":-25.280544,"twenty":-23.568548,"median":27.951968,"eighty":60.876911,"marketCap":136641342198},{"date":"2021-12-23","current":-25.48177,"twenty":-23.634806,"median":27.65765,"eighty":60.876911,"marketCap":137728968216},{"date":"2021-12-31","current":-25.60497,"twenty":-23.766579,"median":27.039995,"eighty":60.876911,"marketCap":138394861697},{"date":"2022-01-07","current":-25.802089,"twenty":-23.903887,"median":26.592299,"eighty":60.865513,"marketCap":139460291266},{"date":"2022-01-14","current":-26.664486,"twenty":-23.969949,"median":26.503175,"eighty":60.865513,"marketCap":144121545629},{"date":"2022-01-21","current":-26.093661,"twenty":-24.000827,"median":26.434777,"eighty":60.865513,"marketCap":141036239169},{"date":"2022-01-28","current":-26.656272,"twenty":-24.081403,"median":26.28969,"eighty":60.865513,"marketCap":144077152730},{"date":"2022-02-04","current":20.625497,"twenty":-24.122181,"median":26.107856,"eighty":60.865513,"marketCap":144254724325},{"date":"2022-02-11","current":20.843465,"twenty":-24.122181,"median":25.804687,"eighty":60.865513,"marketCap":145779193401},{"date":"2022-02-18","current":21.052274,"twenty":-24.122181,"median":24.80247,"eighty":60.865513,"marketCap":147239600991},{"date":"2022-02-25","current":21.441842,"twenty":-24.122181,"median":24.575651,"eighty":60.865513,"marketCap":149964242016},{"date":"2022-03-04","current":21.616368,"twenty":-24.122181,"median":24.306674,"eighty":60.865513,"marketCap":151184881195},{"date":"2022-03-11","current":21.463658,"twenty":-24.122181,"median":23.979644,"eighty":60.865513,"marketCap":150116821913},{"date":"2022-03-18","current":22.133715,"twenty":-24.122181,"median":23.933202,"eighty":60.865513,"marketCap":154803204476},{"date":"2022-03-25","current":22.26692,"twenty":-24.122181,"median":23.737758,"eighty":60.865513,"marketCap":155734841105},{"date":"2022-04-01","current":22.431005,"twenty":-24.122181,"median":23.392104,"eighty":60.865513,"marketCap":156882450469},{"date":"2022-04-08","current":23.631255,"twenty":-24.122181,"median":23.0415,"eighty":60.865513,"marketCap":165277000447},{"date":"2022-04-14","current":23.552252,"twenty":-24.122181,"median":23.0415,"eighty":60.865513,"marketCap":164724447790},{"date":"2022-04-22","current":23.017457,"twenty":-24.122181,"median":22.955165,"eighty":60.865513,"marketCap":160984091344},{"date":"2022-04-29","current":25.636645,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":160254667678},{"date":"2022-05-06","current":26.113479,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":163235357657},{"date":"2022-05-13","current":25.817161,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":161383071741},{"date":"2022-05-20","current":25.949993,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":162213406807},{"date":"2022-05-27","current":25.932963,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":162106953593},{"date":"2022-06-03","current":25.602585,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":160041761251},{"date":"2022-06-10","current":25.575338,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":159871436109},{"date":"2022-06-17","current":25.125751,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":157061071271},{"date":"2022-06-24","current":26.893443,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":168110914838},{"date":"2022-07-01","current":26.17138,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":163597298583},{"date":"2022-07-08","current":25.674111,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":160488864747},{"date":"2022-07-15","current":25.766071,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":161063712101},{"date":"2022-07-22","current":24.846463,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":155315238569},{"date":"2022-07-29","current":23.80824,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":157539125557},{"date":"2022-08-05","current":23.272571,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":153994601994},{"date":"2022-08-12","current":24.385859,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":161361232290},{"date":"2022-08-19","current":24.308413,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":160848771052},{"date":"2022-08-26","current":22.972467,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":152008814698},{"date":"2022-09-02","current":22.139921,"twenty":-24.131516,"median":22.294813,"eighty":60.876911,"marketCap":146499856390},{"date":"2022-09-09","current":22.640094,"twenty":-24.131516,"median":22.251727,"eighty":60.876911,"marketCap":149809501885},{"date":"2022-09-16","current":23.078956,"twenty":-24.131516,"median":22.251727,"eighty":60.876911,"marketCap":152713448900},{"date":"2022-09-23","current":22.817575,"twenty":-24.131516,"median":22.251727,"eighty":60.876911,"marketCap":150983892222},{"date":"2022-09-30","current":22.940198,"twenty":-24.131516,"median":22.251727,"eighty":60.876911,"marketCap":151795289182},{"date":"2022-10-07","current":22.491656,"twenty":-24.131516,"median":22.251727,"eighty":60.876911,"marketCap":148827284512},{"date":"2022-10-14","current":22.788532,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":150791719257},{"date":"2022-10-21","current":23.301613,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":154186774959},{"date":"2022-10-28","current":25.54071,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":170535320356},{"date":"2022-11-04","current":26.188951,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":174863627979},{"date":"2022-11-11","current":25.251495,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":168604229262},{"date":"2022-11-18","current":25.746817,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":171911500215},{"date":"2022-11-25","current":26.34187,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":175884664649},{"date":"2022-12-02","current":26.970165,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":180079793576},{"date":"2022-12-09","current":26.205573,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":174974610226},{"date":"2022-12-16","current":24.430389,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":163121706273},{"date":"2022-12-23","current":24.23093,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":161789919312},{"date":"2022-12-30","current":23.918444,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":159703453073},{"date":"2023-01-06","current":24.267497,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":162034080255},{"date":"2023-01-13","current":24.104606,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":160946454236},{"date":"2023-01-20","current":24.649794,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":164586671930},{"date":"2023-01-27","current":24.08466,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":160813275540},{"date":"2023-02-03","current":26.118629,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":165252565410},{"date":"2023-02-10","current":25.329282,"twenty":-24.131516,"median":22.245911,"eighty":60.555486,"marketCap":160258364307},{"date":"2023-02-17","current":23.588424,"twenty":-24.131516,"median":22.245911,"eighty":60.138319,"marketCap":149243959795},{"date":"2023-02-24","current":23.279927,"twenty":-24.131516,"median":22.245911,"eighty":59.828291,"marketCap":147292098136},{"date":"2023-03-03","current":22.988016,"twenty":-24.131516,"median":22.245911,"eighty":59.303982,"marketCap":145445175275},{"date":"2023-03-10","current":21.79715,"twenty":-24.131516,"median":22.190955,"eighty":58.624659,"marketCap":137910569514},{"date":"2023-03-17","current":22.069158,"twenty":-24.131516,"median":22.143065,"eighty":57.674063,"marketCap":139631565816},{"date":"2023-03-24","current":22.499062,"twenty":-24.131516,"median":22.143065,"eighty":57.089646,"marketCap":142351566870},{"date":"2023-03-31","current":23.040928,"twenty":-24.122181,"median":22.147947,"eighty":56.818785,"marketCap":145779951237},{"date":"2023-04-06","current":23.210469,"twenty":-24.122181,"median":22.147947,"eighty":56.570827,"marketCap":146852635917},{"date":"2023-04-14","current":23.499685,"twenty":-24.131516,"median":22.143065,"eighty":54.708084,"marketCap":148682509782},{"date":"2023-04-21","current":23.114063,"twenty":-24.131516,"median":22.143065,"eighty":52.238402,"marketCap":146242677962},{"date":"2023-04-28","current":19.428023,"twenty":-24.131516,"median":22.133715,"eighty":43.587843,"marketCap":142038275000},{"date":"2023-05-05","current":19.201013,"twenty":-24.131516,"median":22.049255,"eighty":42.979111,"marketCap":140378605761},{"date":"2023-05-12","current":19.850434,"twenty":-24.131516,"median":21.75269,"eighty":40.909864,"marketCap":145126520293},{"date":"2023-05-19","current":18.879176,"twenty":-24.131516,"median":21.57897,"eighty":40.438819,"marketCap":138025656966},{"date":"2023-05-26","current":18.551592,"twenty":-24.131516,"median":21.441842,"eighty":40.037509,"marketCap":135630691229},{"date":"2023-06-02","current":18.586075,"twenty":-24.131516,"median":21.323413,"eighty":39.672401,"marketCap":135882792885},{"date":"2023-06-09","current":18.767108,"twenty":-24.131516,"median":21.067856,"eighty":39.30989,"marketCap":137206326582},{"date":"2023-06-16","current":18.583201,"twenty":-24.131516,"median":20.924495,"eighty":38.76535,"marketCap":135861784414},{"date":"2023-06-23","current":18.764234,"twenty":-24.14085,"median":20.774901,"eighty":37.956903,"marketCap":137185318111},{"date":"2023-06-30","current":18.390674,"twenty":-24.150185,"median":19.657906,"eighty":36.490198,"marketCap":134454216832},{"date":"2023-07-07","current":18.229755,"twenty":-24.150185,"median":19.568826,"eighty":35.727263,"marketCap":133277742434},{"date":"2023-07-14","current":17.896425,"twenty":-24.150185,"median":19.258484,"eighty":33.43663,"marketCap":130840759754},{"date":"2023-07-21","current":18.324582,"twenty":-24.15952,"median":19.11768,"eighty":31.771888,"marketCap":133971021990},{"date":"2023-07-28","current":15.932591,"twenty":-24.15952,"median":18.915095,"eighty":27.682522,"marketCap":126871220392},{"date":"2023-08-04","current":16.063766,"twenty":-24.15952,"median":18.814521,"eighty":27.240851,"marketCap":127915771852},{"date":"2023-08-11","current":16.079507,"twenty":-24.15952,"median":18.65504,"eighty":26.887057,"marketCap":128041118028},{"date":"2023-08-18","current":16.30513,"twenty":-24.15952,"median":18.600443,"eighty":26.661838,"marketCap":129837746540},{"date":"2023-08-25","current":16.076884,"twenty":-24.15952,"median":18.534351,"eighty":26.588154,"marketCap":128020226998},{"date":"2023-09-01","current":16.173954,"twenty":-24.15952,"median":18.403605,"eighty":26.567923,"marketCap":128793195079},{"date":"2023-09-08","current":15.733204,"twenty":-24.15952,"median":18.315962,"eighty":26.505248,"marketCap":125283502172},{"date":"2023-09-15","current":15.607275,"twenty":-24.15952,"median":17.92516,"eighty":26.451358,"marketCap":124280732770},{"date":"2023-09-22","current":15.499711,"twenty":-24.15952,"median":17.785793,"eighty":26.356016,"marketCap":123424200572},{"date":"2023-09-29","current":15.253101,"twenty":-24.15952,"median":17.14351,"eighty":26.308627,"marketCap":121460443826},{"date":"2023-10-06","current":14.801857,"twenty":-24.15952,"median":16.994886,"eighty":26.256528,"marketCap":117867186802},{"date":"2023-10-13","current":14.759881,"twenty":-24.15952,"median":16.912197,"eighty":26.215546,"marketCap":117532930335},{"date":"2023-10-20","current":14.817598,"twenty":-24.15952,"median":16.861517,"eighty":26.181912,"marketCap":117992532978},{"date":"2023-10-27","current":13.009187,"twenty":-24.15952,"median":16.75383,"eighty":26.13539,"marketCap":107781117593},{"date":"2023-11-03","current":12.557292,"twenty":-24.15952,"median":16.645066,"eighty":26.102322,"marketCap":104037163348},{"date":"2023-11-10","current":12.380463,"twenty":-24.15952,"median":16.606678,"eighty":26.050188,"marketCap":102572137774},{"date":"2023-11-17","current":12.486069,"twenty":-24.15952,"median":16.545514,"eighty":25.981328,"marketCap":103447083603},{"date":"2023-11-24","current":12.220826,"twenty":-24.15952,"median":16.468598,"eighty":25.948631,"marketCap":101249545241},{"date":"2023-12-01","current":12.1275,"twenty":-24.15952,"median":16.323182,"eighty":25.871656,"marketCap":100476337299},{"date":"2023-12-08","current":12.319064,"twenty":-24.15952,"median":16.284141,"eighty":25.822267,"marketCap":102063448338},{"date":"2023-12-15","current":12.640794,"twenty":-24.15952,"median":16.244457,"eighty":25.741743,"marketCap":104728980980},{"date":"2023-12-22","current":12.589219,"twenty":-24.15952,"median":16.206012,"eighty":25.671391,"marketCap":104301681854},{"date":"2023-12-29","current":12.579395,"twenty":-24.15952,"median":16.17133,"eighty":25.63392,"marketCap":104220291545},{"date":"2024-01-05","current":12.780784,"twenty":-24.15952,"median":16.126731,"eighty":25.574657,"marketCap":105888792893},{"date":"2024-01-12","current":12.3338,"twenty":-24.15952,"median":16.052442,"eighty":25.53878,"marketCap":102185533803},{"date":"2024-01-19","current":12.301873,"twenty":-24.15952,"median":15.981387,"eighty":25.384604,"marketCap":101921015296},{"date":"2024-01-26","current":12.183987,"twenty":-24.15952,"median":15.915318,"eighty":25.326357,"marketCap":100944331580},{"date":"2024-02-02","current":11.953127,"twenty":-24.15952,"median":15.848219,"eighty":25.326357,"marketCap":99031659303},{"date":"2024-02-09","current":12.350536,"twenty":-24.15952,"median":15.711339,"eighty":25.326357,"marketCap":99113049612},{"date":"2024-02-16","current":12.458223,"twenty":-24.15952,"median":15.581954,"eighty":25.326357,"marketCap":99977242239},{"date":"2024-02-23","current":12.934478,"twenty":-24.15952,"median":15.510205,"eighty":25.326357,"marketCap":103799187786},{"date":"2024-03-01","current":12.788326,"twenty":-24.15952,"median":15.476991,"eighty":25.323432,"marketCap":102626315608},{"date":"2024-03-08","current":13.425852,"twenty":-24.15952,"median":15.421006,"eighty":25.323432,"marketCap":107742464938},{"date":"2024-03-15","current":13.226783,"twenty":-24.15952,"median":15.29517,"eighty":25.323432,"marketCap":106144932143},{"date":"2024-03-22","current":12.999995,"twenty":-24.15952,"median":15.228111,"eighty":25.323432,"marketCap":104324958073},{"date":"2024-03-28","current":13.418293,"twenty":-24.15952,"median":15.187513,"eighty":25.323432,"marketCap":107681799135},{"date":"2024-04-05","current":12.981358,"twenty":-24.15952,"median":15.120443,"eighty":25.326357,"marketCap":104175397951},{"date":"2024-04-12","current":12.405531,"twenty":-24.15952,"median":15.050664,"eighty":25.326357,"marketCap":99554388080},{"date":"2024-04-19","current":12.198436,"twenty":-24.15952,"median":15.01354,"eighty":25.326357,"marketCap":97892445934},{"date":"2024-04-26","current":-14.73835,"twenty":-24.15952,"median":14.996944,"eighty":25.323432,"marketCap":90611374291},{"date":"2024-05-03","current":-14.408633,"twenty":-24.15952,"median":14.996944,"eighty":25.323432,"marketCap":88584274195},{"date":"2024-05-10","current":-14.751538,"twenty":-24.15952,"median":14.897686,"eighty":25.323432,"marketCap":90692458295},{"date":"2024-05-17","current":-14.543817,"twenty":-24.15952,"median":14.883186,"eighty":25.323432,"marketCap":89415385234},{"date":"2024-05-24","current":-13.696444,"twenty":-24.15952,"median":14.851704,"eighty":25.323432,"marketCap":84205737987},{"date":"2024-05-31","current":-13.271109,"twenty":-24.15952,"median":14.843629,"eighty":25.323432,"marketCap":81590778864},{"date":"2024-06-07","current":-13.478831,"twenty":-24.15952,"median":14.843629,"eighty":25.323432,"marketCap":82867851924},{"date":"2024-06-14","current":-13.676661,"twenty":-24.15952,"median":14.80891,"eighty":25.326357,"marketCap":84084111982},{"date":"2024-06-21","current":-13.531586,"twenty":-24.15952,"median":14.706868,"eighty":25.329282,"marketCap":83192187939},{"date":"2024-06-28","current":-13.686553,"twenty":-24.161675,"median":14.733375,"eighty":25.346437,"marketCap":84144924984},{"date":"2024-07-05","current":-13.208463,"twenty":-24.161675,"median":14.649759,"eighty":25.346437,"marketCap":81205629845},{"date":"2024-07-12","current":-13.435968,"twenty":-24.161675,"median":14.578971,"eighty":25.346437,"marketCap":82604328912},{"date":"2024-07-15","current":-13.34035,"twenty":-24.161675,"median":14.578971,"eighty":25.346437,"marketCap":82016469884},{"date":"2024-08-02","current":-14.930382,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":97659625724},{"date":"2024-08-09","current":-14.521245,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":94983464089},{"date":"2024-08-16","current":-15.221736,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":99565377191},{"date":"2024-08-23","current":-14.759908,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":96544558376},{"date":"2024-08-30","current":-15.410807,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":100802088250},{"date":"2024-09-06","current":-15.435603,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":100964279864},{"date":"2024-09-13","current":-14.952078,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":97801543386},{"date":"2024-09-20","current":-15.193841,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":99382911625},{"date":"2024-09-27","current":-15.534788,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":101613046321},{"date":"2024-10-04","current":-16.799391,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":109884818647},{"date":"2024-10-11","current":-16.241478,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":106235507327},{"date":"2024-10-18","current":-16.48324,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":107816875566},{"date":"2024-10-25","current":-16.402653,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":107289752819},{"date":"2024-10-31","current":-16.322065,"twenty":-24.197578,"median":14.812351,"eighty":25.39607,"marketCap":106762630073},{"date":"2024-11-08","current":-15.288171,"twenty":-24.199732,"median":13.697044,"eighty":25.3977,"marketCap":110961545834},{"date":"2024-11-15","current":-16.347249,"twenty":-24.199732,"median":13.400607,"eighty":25.3977,"marketCap":118648335429},{"date":"2024-11-22","current":-16.2718,"twenty":-24.199732,"median":13.207884,"eighty":25.3977,"marketCap":118100727727},{"date":"2024-11-29","current":-16.548446,"twenty":-24.199732,"median":13.07937,"eighty":25.3977,"marketCap":120108622634},{"date":"2024-12-06","current":-16.442259,"twenty":-24.199732,"median":13.01341,"eighty":25.3977,"marketCap":119337915498},{"date":"2024-12-13","current":-15.726892,"twenty":-24.199732,"median":12.968664,"eighty":25.320507,"marketCap":114145783212},{"date":"2024-12-20","current":-15.732481,"twenty":-24.199732,"median":12.88985,"eighty":25.094333,"marketCap":114186346746},{"date":"2024-12-27","current":-16.207529,"twenty":-24.199732,"median":12.836673,"eighty":24.91965,"marketCap":117634247092},{"date":"2025-01-03","current":-15.869407,"twenty":-24.199732,"median":12.825525,"eighty":24.830114,"marketCap":115180153316},{"date":"2025-01-10","current":-15.874995,"twenty":-24.201887,"median":12.736577,"eighty":24.700357,"marketCap":115220716849},{"date":"2025-01-17","current":-15.754836,"twenty":-24.201887,"median":12.665354,"eighty":24.382395,"marketCap":114348600880},{"date":"2025-01-24","current":-16.526091,"twenty":-24.201887,"median":12.629443,"eighty":24.315777,"marketCap":119946368500},{"date":"2025-01-31","current":-16.526091,"twenty":-24.201887,"median":12.589219,"eighty":24.176109,"marketCap":119946368500},{"date":"2025-02-07","current":-16.045454,"twenty":-24.201887,"median":12.557292,"eighty":24.139507,"marketCap":116457904621},{"date":"2025-02-14","current":-12.693406,"twenty":-24.201887,"median":12.48999,"eighty":24.058649,"marketCap":113580593927},{"date":"2025-02-21","current":-12.652584,"twenty":-24.201887,"median":12.441862,"eighty":24.03394,"marketCap":113215317763},{"date":"2025-02-28","current":-13.33522,"twenty":-24.201887,"median":12.405023,"eighty":23.957965,"marketCap":119323546952},{"date":"2025-03-07","current":-13.648189,"twenty":-24.204041,"median":12.35322,"eighty":23.91379,"marketCap":122123997544},{"date":"2025-03-14","current":-13.670868,"twenty":-24.204041,"median":12.333293,"eighty":23.792996,"marketCap":122326928746},{"date":"2025-03-21","current":-13.702619,"twenty":-24.204041,"median":12.308013,"eighty":23.674229,"marketCap":122611032429},{"date":"2025-03-28","current":-13.357899,"twenty":-24.204041,"median":12.274857,"eighty":23.602452,"marketCap":119526478154},{"date":"2025-04-04","current":-13.14819,"twenty":-24.204041,"median":12.234334,"eighty":23.545063,"marketCap":117650007992},{"date":"2025-04-11","current":-11.474536,"twenty":-24.201887,"median":12.193385,"eighty":23.482347,"marketCap":102674150870},{"date":"2025-04-17","current":-11.224398,"twenty":-24.201887,"median":12.165443,"eighty":23.454761,"marketCap":100435911354},{"date":"2025-04-23","current":-11.329001,"twenty":-24.204041,"median":12.060673,"eighty":23.368181,"marketCap":101371902424}],"updateTime":1745501411375}}}